Pharmaceutical controlled substances have a useful and legitimate medical purpose, but they can also have a substantial and detrimental effect on public health and welfare when they are diverted or abused.

At 801 Consulting, we help clients such as prescribers, pharmacies, hospitals, clinics, narcotic treatment programs, distributors, manufacturers, importers/exporters, and disposal companies, as well as local, state, and federal governmental entities, navigate complex controlled substance laws and regulations, and develop and maintain flexible, effective diversion control programs and policies.

We do this by comprehensively reviewing manufacturing, distribution, and dispensing systems and processes, analyzing and identifying problem areas, and recommending opportunities to implement proactive and/or corrective measures, with a focus on helping clients fulfill their legal obligations.

Meet Our Team

Our thorough and detailed understanding of laws and regulations at 801 Consulting is based on over 75 years of collective experience in the pharmaceutical drug control arena. We use our unmatched technical expertise to guide and collaborate with clients to design solutions that will make a difference. We offer what no one else can: the combined experience of established experts in the field of diversion control.

Our strength lies in the depth and diversity of our experience. Together, we turn complex compliance requirements into scalable compliance processes by partnering with our clients from reviewing, planning, and implementation through ongoing review, training, and monitoring to deliver compliance solutions that are strong, flexible, and on target.

801 Consulting

Meet Our Team

801 Consulting

Our thorough and detailed understanding of laws and regulations at 801 Consulting is based on over 75 years of collective experience in the pharmaceutical drug control arena. We use our unmatched technical expertise to guide and collaborate with clients to design solutions that will make a difference. We offer what no one else can: the combined experience of established experts in the field of diversion control.

Our strength lies in the depth and diversity of our experience. Together, we turn complex compliance requirements into scalable compliance processes by partnering with our clients from reviewing, planning, and implementation through ongoing review, training, and monitoring to deliver compliance solutions that are strong, flexible, and on target.

Mimi-Paredes

Mimi Paredes

President

Mimi Paredes was an attorney in the DEA Office of Chief Counsel, where she represented the agency in enforcement actions to revoke registrants’ authority to handle controlled substances.

Joseph-Rannazzisi

Joseph Rannazzisi

Strategic Partner

Joseph Rannazzisi was the Deputy Assistant Administrator for the DEA Office of Diversion Control and retired from the DEA Senior Executive Service with over 29 years of federal law enforcement experience as a special agent/investigator.

Ruth-Carter

Ruth Carter

Strategic Partner

Ruth Carter retired from the DEA as a senior manager with over 30 years of experience as a diversion investigator, having worked at DEA headquarters and five field offices.

Mimi-Paredes

Mimi Paredes

President

Mimi Paredes was an attorney in the DEA Office of Chief Counsel, where she represented the agency in enforcement actions to revoke registrants’ authority to handle controlled substances.

Joseph-Rannazzisi

Joseph Rannazzisi

Strategic Partner

Joseph Rannazzisi was the Deputy Assistant Administrator for the DEA Office of Diversion Control and retired from the DEA Senior Executive Service with over 29 years of federal law enforcement experience as a special agent/investigator.

Ruth-Carter

Ruth Carter

Strategic Partner

Ruth Carter retired from the DEA as a senior manager with over 30 years of experience as a diversion investigator, having worked at DEA headquarters and five field offices.